4-单取代-1H-1,2,3-三氮唑的合成研究

以甲氧基聚乙二醇(mPEG)为起始原料通过磺酰化、叠氮化反应合成叠氮基甲氧基聚乙二醇(mPEG-N_3,2);在铜催化下和芳香炔、脂肪炔发生1,3-偶极环加成反应合成甲氧基聚乙二醇-1,2,3-三氮唑(mPEG-1,2,3-triazoles,3);再于酸性条件下脱除甲氧基聚乙二醇(mPEG)制备4-单取代-1H-1,2,3-三氮唑(4),其结构经过MS及~1H NMR、~(13)C NMR确证。     

1-(4-取代苯基)-4-苯基-5-(2-羟基苄基)氨基-1,2,3-三唑类衍生物的合成及抑菌活性

将邻羟苯基引入1,2,3-三唑结构中, 设计合成了10个1-(4-取代苯基)-4-苯基-5-取代-1,2,3-三唑类衍生物. 首先, 以对位取代的芳胺为原料, 经重氮化、叠氮化、闭环和缩合反应制得1-(4-取代苯基)-4-苯基-5-水杨醛亚胺-1,2,3-三唑类衍生物(3a~3e), 再用硼氢化钠还原制得1-(4-取代苯基)-4-苯基-5-(2-羟基苄基)氨基-1,2,3-三唑类衍生物(4a~4e). 目标化合物的结构经核磁、IR及元素分析确认. 抑菌活性测试表明, 当质量浓度为0.1 mg/L时, 除化合物3e和4e外, 所有化合物对白色念球菌的抑菌率均达95%以上, 对大肠杆菌的抑菌率达85%以上, 具有强抑菌活性, 表明该类化合物在抗菌药物开发方面有重要应用价值.     

铜催化的2H-1,2,3-三氮唑的绿色制备

报道了4-取代-1-磺酰基-1,2,3-三氮唑在绿色溶剂中的催化水解反应,以1 mol％硫酸铜作为催化剂,在水/PEG-400混合溶剂中以较高的收率高效合成了4-取代-2H-1,2,3-三氮唑.该方法为制备2H-1,2,3-三氮唑类化合物提供了一种绿色、简单、有效的方法.此外,还用一锅法对2H-1,2,3-三氮唑进行了...     

福司氟康唑杂质——2-(2,4-二氟苯基)-1-(1H-1,2,4-三氮唑-1-基)-3-(4H-1,2,4-三氮唑-4-基)-2-丙基磷酸二氢酯的合成

以1,3-二氟苯为起始原料,依次经傅－克酰基化,1H-三氮唑取代,环氧化,胺解,4H-三氮唑环化,磷酸酯化和钯碳加氢反应等7步反应合成了福司氟康唑的主要杂质--2-(2,4-二氟苯基-1-(1H-1,2,4-三氮唑-1-基)-3-(4H-1,2,4-三氮唑-4-基)-2-丙基磷酸二氢酯,纯度98%,总收率7.8%,其结构经¹H NMR确证。     

1-甲基-4-苯基-1H-1,2,3-三唑-5-甲酸衍生物的定向合成

1-甲基-4-苯基-1H-1,2,3-三唑-5-甲酸是一类重要的三唑类衍生物,是多种药物合成的重要中间体.以苯乙炔为原料,设计出了一条定向合成1-甲基-4-苯基-1H-1,2,3-三唑-5-甲酸的新方法.首先苯乙炔与叠氮化钠、碘甲烷在碘化亚铜催化下反应生成1-甲基-4-苯基-1H-1,2,3-三唑,再依次与正丁基锂、甲酸乙酯反应生成中间体1-甲基-4-苯基-1H-1,2,3-三唑-5-甲醛后直接氧化生成目标化合物.该合成途径原料易得、总产率较高、后处理操作简便,具有较高的应用价值.     

2-(4-甲基苯基)-3-(N-乙酰基)-5-(2-羟基苯基)-1,3,4-噁唑啉的合成及与人血清白蛋白的相互作用

合成了2-(4-甲基苯基)-3-(N-乙酰基)-5-(2-羟基苯基)-1,3,4-噁唑啉(MPAHO),并用核磁共振波谱法和红外光谱法对其进行了表征。采用荧光光谱技术研究了MPAHO与人血清白蛋白(HSA)的相互作用。结果表明:MPAHO对HSA有较强的荧光猝灭作用,根据Stern-Volmer方程得到的荧光猝灭常数,可判断由于与MPAHO反应而导致HSA的荧光猝灭均属于静态猝灭。采用位点结合模型公式和Frster非辐射能量转移理论计算了结合常数、结合位点数、结合距离。从计算得到的热力学参数焓变ΔH和熵变ΔS,推断MPAHO与HSA之间的作用力为静电引力。并应用同步荧光光谱和三维荧光技术研究了MPAHO对HSA构象的影响。     

1-(5-羧基-1,3,4-三氮唑基)-3-[4-(4-硝基苯基偶氮)苯基] -三氮烯与镉的显色反应及其应用

１ 引 言 三氮烯类试剂是一类广泛用于测定镉、汞、银等元素的显色剂。近年来，为了改善该类试剂的分析性能，人们努力合成了许多取代苯类、吡啶类、苯并噻唑类三氮烯显色剂，但此类试剂灵敏度仍不够高，选择性也不够理想，苯并噻唑类三氮烯显色剂虽灵敏度较高，但选择性仍不理想。作者在研究取代苯类、吡啶类三氮烯显色剂的基础上，又设计合成１－（５－羧基－１，３，４－三氮唑基）－３－［４－（－硝基苯基偶氮）苯基］三氮烯（ＣＴＺＮＰＡＰＴ），研究结果表明，试剂与镉有高灵敏反应，并有较好的选择性，摩尔吸光系数２．４６× １０…     

5-苯基-2-(3-三氟甲苯)-2H-1,2,3-三氮唑-4-羧酸乙酯的结构性质及其罗丹明B衍生物对Hg~(2+)的显色响应

对一种新合成的化合物5-苯基-2-(3-三氟甲苯)-2H-1,2,3-三氮唑-4-羧酸乙酯(EPFC),利用Gauss View5.0量化程序及含时密度泛函TD-DFT方法对其结构性质及理论光谱进行了计算;并将其与罗丹明B反应合成了一种新型含有1,2,3-三氮唑基团的化合物REPFC,通过核磁共振及高分辨质谱对其进行了结构表征;应用紫外吸收和荧光分析法研究了REPFC与15种金属离子的作用.结果表明:EPFC易失去电子,计算光谱与实验光谱的结果较好地吻合;在一定浓度范围内,肉眼可观察到REPFC仅对Hg~(2+)有粉红色的显色反应,使其荧光增强,并且反应时间很快,不受其他金属离子的影响,反应络合比为1∶2,提出了REPFC与Hg~(2+)显色反应的off-on机理模型,研究结果可为进一步开发此类三氮唑化合物在生理条件下的应用提供理论指导.     

气相色谱法测定1-(5-溴-1H-吲唑-1-基)乙酮

建立了测定1-(5-溴-1H-吲唑-1-基)乙酮纯度的气相色谱法。采用DB–5型色谱柱,程序升温,火焰光度检测器,外标法定量,1-(5-溴-1H-吲唑-1-基)乙酮在100~1 000 mg/L范围内内线性关系良好,检出限为0.01mg/L。测定结果的相对标准偏差为1.67%~1.89%(n=5),样品加标回收率为98.1%~107.9%。用该方法测定了自制的1-(5-溴-1H-吲唑-1-基)乙酮样品的纯度。该测定方法准确度高、专属性较强且灵敏度较高,适用于1-(5-溴-1H-吲唑-1-基)乙酮的质量控制。     

含1-[4-二-(4-氟苯)甲基]哌嗪官能团的1,2,3-三氮唑衍生物的合成及抗肿瘤活性研究

以1-[二-(4-氟苯)甲基]哌嗪、苄溴、溴丙炔及NaN_3为原料,应用5 mol%的CuBr2或CuI为催化剂,DMF-H_2O为溶剂,在70℃反应4h以43~83%的收率制得了8个含有1-[4-二-(4-氟苯)甲基]哌嗪基官能团的-1,2,3-三氮唑衍生物4(a~h)。合成的8个目标化合物通过熔点测定和质谱、红外光谱、核磁共振氢谱分析对其结构进行确证.经体外抗肿瘤活性测试表明有6个化合物对CDC25b具有较好的抑制活性,其抑制率为78~97%,IC_(50)可为16.91~11.55μM。化合物4b,4c及4g对白血病HL-60肿瘤细胞生长的抑制率分别为98%,97%和93%,IC_(50)分别为10.99μM,8.82μM和15.23μM;对肺癌A-549肿瘤细胞生长的抑制率分别可达90%,88%和73%,IC_(50)可分别达21.11μM,13.51μM和16.12μM。化合物4c对肝癌SMMC-7721细胞生长的抑制率可高达91%,IC_(50)可达16.26μM。     

Rearrangement of 5-hydroxy-1-(4-tolyl)-4-N-methylcarbamoyl-1,2,3-triazole to 5-hydroxy-1-methyl-4-N-(4-tolyl)-carbamoyl-1,2,3-triazole

Translated from Izvestiya Akademii Nauk SSSR, Seriya Khimicheskaya, No. 12, p. 2875, December, 1989.     

2-Alkyl-4-amino-5-(tert-butyl-NNO-azoxy)-2H-1,2,3-triazole 1-oxides: synthesis and reduction

A new approach to the synthesis of 4-amino-5-(tert-butyl-NNO-azoxy)-2-R-2H-1,2,3-triazole 1-oxides 1 was developed. Compounds 1 were obtained by reactions of 3-amino-4-(tert-butyl-NNO-azoxy)furoxan with aliphatic amines RNH₂ (R = Me, Et, Prⁱ, Bu, and Bu^t). 4-Amino-5-(tert-butyl-NNO-azoxy)-2-tert-butyl-2H-1,2,3-triazole 1-oxide was transformed under the action of acids into 4-amino-5-(tert-butyl-NNO-azoxy)-1-hydroxy-1H-1,2,3-triazole. Methylation of the latter with diazomethane mainly involves the O atom of the triazole oxide ring. Reduction of compounds 1 gave 4-amino-5-(tert-butyl-NNO-azoxy)-2-R-2H-1,2,3-triazoles and 4-amino-5-(tert-butyldiazenyl)-2-R-2H-1,2,3-triazoles (R = Me, Prⁱ, and Bu^t). The structures of the compounds obtained were confirmed by ¹H, ¹³C, and ¹⁴N NMR spectroscopy.     

Synthesis,Crystal Structure and Antimicrobial Activity of Ethyl 2-（1-cyclohexyl-4-phenyl-1H-1,2,3-triazol-5-yl）-2-oxoacetate

A novel 1,4,5-trisubstituted 1,2,3-triazole(C18H21N3O3) was synthesized by a one-pot three component reaction of 1-azidocyclohexane, 1-copper(I) phenylethyne and ethoxalyl chloride at room temperature. The molecular structure was determined by single-crystal X-ray analysis. The compound crystallizes in the monoclinic system, space group P21/n with a = 12.8167(9), b = 8.0966(6), c = 16.7079(9) , β = 98.716(2)o, Z = 4 and V = 1713.8(2). In the crystal, the molecules are related by inversion and paired into dimers via C–H···O and C–O···C interactions involving(oxo) acetate groups. Furthermore, X-ray analysis results are compared with the optimized structure computed by using B3 LYP method with 6-311 G basis set. The calculated results showed that optimized geometry can well reproduce the crystal structure parameters. The bioassay results indicate that the compound has good antibacterial and antifungal activities.     

3-取代硫基-5-(1-羟基苯基)-4H-1,2,4-三唑类化合物的合成及抑菌活性

依据邻羟基二苯醚及三唑类化合物的抗菌特性及生物活性叠加原理, 将邻羟苯基和1,2,4-三唑分子片断有机结合, 设计合成了12个新型3-取代硫基-5-(1-羟基苯基)-4H-1,2,4-三唑类化合物. 首先, 水杨酸甲酯与水合肼反应生成水杨酰肼, 水杨酰肼再与硫氰酸铵和盐酸反应, 生成5-(1-羟基苯基)-4H-1,2,4-三唑-3-硫酮(3), 最后在碱性条件下化合物3与取代苯乙酮、氯苄和碘甲烷发生烷基化反应生成目标化合物, 化合物结构经 1H NMR及IR等表征确认. 抑菌测试结果表明, 当化合物质量分数为0.01%时, 目标化合物对白色念珠菌和大肠杆菌的抑菌率高达90%, 具有强抑菌活性; 对金黄色葡萄球菌的抑菌率高达80%, 具有一定的抑菌活性.     

Functionalisation of 1,2,3-triazole via lithiation of 1-[2-(trimethylsilyl)ethoxy]methyl-1H-1,2,3-triazole

The preparation of a number of 5-substituted 1-[2-(trimethylsilyl)ethoxy]methyl-1H-1,2,3-triazoles via reaction of 1-[2-(trimethylsilyl)ethoxy]methyl-1H-1,2,3-triazole with n-butyllithium followed by addition of various electrophiles is reported. Removal of the protecting group by action of diluted aqueous hydrochloric acid or by tetrabutylammonium fluoride in tetrahydrofuran leads to the appropriate 4-substituted 1H-1,2,3-triazoles.     

One-pot Synthesis,Characterization and Crystal Structure Determination of Novel 1,4,5-Trisubstituted 1,2,3-Triazole with Two Conformational Isomers: 1-Benzyl-5-((4-methoxyphenyl)ethynyl)-4-phenyl-1H-1,2,3-triazole

The title compound l-benzyl-5-((4-methoxyphenyl)ethynyl)-4-phenyl-1H-1,2,3-triazole(C_(24)H_(19)N_3O) was designed and synthesized using one-pot strategy and structural characterization was done by single-crystal X-ray diffraction,NMR,IR and MS.This compound was crystallized out from an ethanolic solution in triclinic system,space group P1 with a =9.9038(9),b = 10.2928(9),c = 18.8715(19) ?,α = 103.541(6),β = 90.507(7),γ = 97.157(7)°,V =1854.2(3) ?~3,Z = 4,crystal size(mm) = 0.25 × 0.1 × 0.1 and R_(int) = 0.068.Its asymmetric unit contains two independent molecules.The crystal structure of the title compound is stabilized by intramolecular interactions of types C-H…N and C-H…O.Additionally,X-ray analysis reveals obvious C-H…π,π-π stacking interactions between two adjacent aromatic ring planes.